Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $279.0M | $322.9M | $379.5M | $463.5M | $529.8M | $526.3M | $578.6M | $646.5M | $699.1M | $756.1M | $816.1M | $890.3M | $975.4M | $1,097.4M | $1,241.5M | $1,365.5M | $1,571.0M | $1,889.4M | $2,004.3M | $2,190.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, IDEXX Laboratories, Inc.'s last 12-month Gross Profit is $2,380.6M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, IDEXX Laboratories, Inc.'s Gross Profit growth was 8.7%. The average annual Gross Profit growth rates for IDEXX Laboratories, Inc. have been 9.9% over the past three years, 11.8% over the past five years.
Over the last year, IDEXX Laboratories, Inc.'s Gross Profit growth was 8.7%, which is higher than industry growth of 0.1%. It indicates that IDEXX Laboratories, Inc.'s Gross Profit growth is Good.